Generate a tailored SOP for Dr. Francine Foss. Improve your application with a focused, well-structured draft.
Francine Foss, MD, is a Professor of Medicine at the Yale School of Medicine, known for her expertise in hematologic oncology and stem cell transplantation. She has significantly impacted the field of adult lymphoma treatment, developing therapies that have benefited thousands of cancer patients. Dr. Foss established a nationally recognized clinical trials program at Yale Cancer Center and has led multi-center clinical trials resulting in FDA approvals of novel lymphoma therapies, including the Interleukin-2 conjugated Diphtheria toxin. Her research focuses on elucidating mechanisms of treatments such as extracorporeal photopheresis and has led to groundbreaking trials for patients with lymphoma and myelodysplastic syndrome. Additionally, Dr. Foss is a co-founder of the United States Cutaneous Lymphoma Consortium and serves as its President, promoting collaboration among oncologists to develop innovative clinical trials.
Yale Cancer Center • New Haven, CT
Leading a specialized program focused on T cell lymphomas, developing innovative treatments and clinical trials.
Yale Cancer Center • New Haven, CT
Overseeing research and clinical activities related to lymphoma treatments and therapies.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.